Samuel Rubinstein - 29 May 2026 Form 4 Insider Report for MediWound Ltd. (MDWD)

Reporting relationship: Director
Issuer ticker: MDWD
Reported as of: 29 May 2026
Net transaction value: +$2,150
SEC form: 4
Accepted by SEC: 01 Jun 2026, 07:00:39 UTC
Prior SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Yaron Meyer, attorney-in-fact

Key filing fact

Samuel Rubinstein filed Form 4 for MediWound Ltd. (MDWD) on 01 Jun 2026.

Key facts

This page summarizes Samuel Rubinstein's Form 4 filing for MediWound Ltd. (MDWD).
1 reported transaction and 4 derivative rows are listed below.
Accepted by SEC: 01 Jun 2026, 07:00.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: +$2,150.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001742152 Primary reporting owner

Rubinstein Samuel

Relationship: Director
Address: C/O MEDIWOUND LTD., 42 HAYARKON STREET, YAVNE, ISRAEL
Signature: /s/ Yaron Meyer, attorney-in-fact
Signature date: 01 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDWD transaction

Ordinary Shares

Purchase

Transaction value: $2,150
Shares: +150
Change %: +5.3%
Price: $14.33
Shares after: 2,993
Date: 29 May 2026
Ownership: Direct

MDWD holding

Ordinary shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 750
Date: 29 May 2026
Ownership: Direct
Footnotes: F1, F2

MDWD holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 525
Date: 29 May 2026
Ownership: By spouse
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MDWD holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,200
Date: 29 May 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 7,200
Exercise price: $9.64
Footnotes: F2

MDWD holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,542
Date: 29 May 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 7,542
Exercise price: $12.73
Footnotes: F2

MDWD holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,600
Date: 29 May 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 5,600
Exercise price: $18.54
Footnotes: F2

MDWD holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 6,250
Date: 29 May 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 6,250
Exercise price: $17.60
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.

Footnote F2

There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.

Footnote F3

The options reported in this row were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .